Cas:863868-30-8 4-chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile manufacturer & supplier

We serve Chemical Name:4-chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile CAS:863868-30-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4-chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile

Chemical Name:4-chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile
CAS.NO:863868-30-8
Synonyms:4-chloranyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenecarbonitrile
Molecular Formula:C13H15BClNO2
Molecular Weight:263.52800
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:42.25000
Exact Mass:263.08800
LogP:2.51088

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 4-chloranyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenecarbonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-chloranyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenecarbonitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-chloranyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenecarbonitrile Use and application,4-chloranyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenecarbonitrile technical grade,usp/ep/jp grade.


Related News: AstraZeneca’s application for anifrolumab in SLE is under review by regulatory authorities in the US, EU and Japan, with decisions anticipated in the second half of 2021. Anifrolumab is not currently approved in any country. 1H-Benzimidazole-6-carboxylic acid, 2-methyl-1-[(2-nitrophenyl)methyl]- manufacturers One of the engineered IgM antibodies, IGM-6268, demonstrated a significantly increased potency against the original SARS-CoV-2 and emerging variants such as the current U.K., South African, and Brazilian variants of concern (VOC) and variants of interest (VOI) 2-(4-(4-chloro-2-fluorobenzamido)-1-methyl-1H-pyrrol-2-yl)-N-(2-morpholinoethyl)-1H-benzo[d]imidazole-5-carboxamide suppliers “The most important thing to be considered while determining a CDMO competency is their technical knowledge along with adequate expertise to accomplish the drug development till commercial scaling. (Z)-3-(3-bromo-5-(1-propynyl)-2-thienyl)acrylic acid vendor & factory.